Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Awakn Life Sciences Corp (AWKNF)

Awakn Life Sciences Corp (AWKNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AWKNF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0700 +81.14%
on 05/01/24
0.1877 -32.45%
on 04/09/24
+0.0323 (+34.18%)
since 04/03/24
3-Month
0.0700 +81.14%
on 05/01/24
0.1877 -32.45%
on 04/09/24
+0.0328 (+34.89%)
since 02/02/24
52-Week
0.0422 +200.47%
on 11/17/23
0.3370 -62.37%
on 05/22/23
-0.1742 (-57.87%)
since 05/03/23

Most Recent Stories

More News
Awakn Life Sciences Discusses Filing of Financial Statements

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.1268 (+0.32%)
AWKN.CN : 0.1700 (+6.25%)
Awakn Life Sciences Announces Closing of Tranche of Private Placement

Toronto, Ontario--(Newsfile Corp. - April 17, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.1268 (+0.32%)
AWKN.CN : 0.1700 (+6.25%)
Awakn Life Sciences Announces Launch of Licensing Partnership Agreement with Oklahoma Based Clinic

Awakn also announces Private PlacementToronto, Ontario--(Newsfile Corp. - April 3, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company") a clinical-stage biotechnology...

AWKNF : 0.1268 (+0.32%)
AWKN.CN : 0.1700 (+6.25%)
Awakn Life Sciences Announces Listing on the Canadian Securities Exchange

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.1268 (+0.32%)
AWKN.CN : 0.1700 (+6.25%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Announces Conditional Approval of CSE Listing

Toronto, Ontario--(Newsfile Corp. - February 5, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing medication-assisted...

AWKNF : 0.1268 (+0.32%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers

Awakn Designates Program AWKN-002 for Alcohol Use Disorders in the US MarketToronto, Ontario--(Newsfile Corp. - January 24, 2024) - Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"),...

AWKNF : 0.1268 (+0.32%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Enters Global Licensing Agreement For Proprietary Sublingual S-Ketamine Formulation With LTS

Agreement Includes Exclusive Rights for Treatment of Addiction, Anxiety and Eating DisordersAlso Includes Access to Phase 1 Data and Patents Filed in US and Key International MarketsToronto, Ontario--(Newsfile...

AWKNF : 0.1268 (+0.32%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - December 15, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing therapeutics to...

AWKNF : 0.1268 (+0.32%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Receives Regulatory and Ethical Approval for Phase III Clinical Trial of AWKN-P001

AWKN-P001 is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for the Treatment of Severe Alcohol Use DisorderToronto, Ontario--(Newsfile Corp. - November...

AWKNF : 0.1268 (+0.32%)
AWKN.NE : 0.1100 (-21.43%)
Awakn Life Sciences Announces Receipt of Notice of Non-Compliance with Cboe Exchange Continued Listing Requirements

Toronto, Ontario--(Newsfile Corp. - November 10, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a clinical-stage biotechnology company developing therapeutics to treat...

AWKNF : 0.1268 (+0.32%)
AWKN.NE : 0.1100 (-21.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.1390
2nd Resistance Point 0.1365
1st Resistance Point 0.1317
Last Price 0.1268
1st Support Level 0.1244
2nd Support Level 0.1219
3rd Support Level 0.1171

See More

52-Week High 0.3370
Fibonacci 61.8% 0.2244
Fibonacci 50% 0.1896
Fibonacci 38.2% 0.1548
Last Price 0.1268
52-Week Low 0.0422

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar